Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

sintilimab × Lymphoid × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 13 Tumor-Agnostic 1 Thoracic 1 Lymphoid 1 Gynecologic 1 Breast 1

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

Rituximab 80 Cyclophosphamide 75 Specimen Handling 68 Magnetic Resonance Spectroscopy 54 Biopsy 49 Vincristine 45 Prednisone 43 Doxorubicin 43 venetoclax 37 obinutuzumab 37 ibrutinib 34 fludarabine 26 Lenalidomide 26 Dexamethasone 25 acalabrutinib 21 Gemcitabine 21 blinatumomab 20 Cytarabine 20 CT-P10 20 prednylidene 19 deltacortene 19 glofitamab 17 Methotrexate 17 Etoposide 17 Bendamustine Hydrochloride 17 Calcium Dobesilate 15 zanubrutinib 14 X-Rays 14 Nivolumab 14 pembrolizumab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04512534 2026-04-02

Sincerely20

Fudan University

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡